Key result
Depression screening using the PHQ-9 is most clinically useful when combined with coordinated follow-up, treatment monitoring, and an operational cut-off score range of 8 to 12.
Answers are grounded in this paper and cite their sources.
Supports coordinated follow-up with PHQ-9 screening; leaves open randomized validation of 8-12 thresholds in cardiovascular populations.
See related research article by Manea and colleagues on page [E191][1] and at [www.cmaj.ca/lookup/doi/10.1503/cmaj.110829][2] Screening has a checkered legacy in health care. Too often, clinicians have been advised to screen for a variety of diseases or risk factors in advance of evidence that
No takes yet. Share an insight, caveat, or question.
Kurt Kroenke (2012) conducted an editorial in Depression. Depression screening (PHQ-9) was evaluated. Depression screening using the PHQ-9 is most clinically useful when combined with coordinated follow-up, treatment monitoring, and an operational cut-off score range of 8 to 12.
Synapse has enriched 10 related papers. Consider them for comparative context: